DiCE Molecules SV, LLC Company Profile

11:24 EDT 18th June 2018 | BioPortfolio

DiCE Molecules is a privately held company focused on the development of small molecule compounds that unlock previously intractable targets. DiCE’s platform uniquely brings the full power of directed evolution to the field of medicinal chemistry for the first time. The company is focused on leveraging its capabilities to create a self-financing business generating returns for its shareholders through the achievement of milestones and revenues secured by collaborations while advancing its internal drug discovery efforts. For more information, visit

News Articles [238 Associated News Articles listed on BioPortfolio]

Genentech seals deal with DiCE Molecules

Genentech has followed in the footsteps of its parent company by signing a drug discovery agreement with DiCE Molecules. The pact will see the two companies enter a multi-year collaboration to identif...

Deals this week: DiCE Molecules, Entrega, Ono Pharmaceutical

US-based biotechnology company DiCE Molecules has signed an agreement to discover new small molecules against multiple targets using its technology...Read More... The post Deals this week: DiCE Molecu...

Roche and DiCE Molecules enter into drug discovery collaboration

San Franciscan startup DiCE Molecules has reached an agreement with Roche’s biotech arm Genentech to…

Genentech signs small-molecule discovery agreement with DiCE

In a multi-year alliance, DiCE Molecules SV LLC will discover and develop small molecules against targets selected by Roche's Genentech Inc.

Genentech, DiCE in small molecule collaboration

Global Warming Rolls Dice on MI; TAVR 'Failure to Rescue'; BVS Decline

(MedPage Today) -- A bevy of studies to note from ACC while awaiting the late-breakers

Silver nanoparticles take spectroscopy to new dimension

As medicine and pharmacology investigate nanoscale processes, it has become increasingly important to identify and characterize different molecules. Raman spectroscopy, a technique that leverages the...

Less is more when it comes to predicting molecules’ conductivity

Drugs and Medications [11 Associated Drugs and Medications listed on BioPortfolio]

Voluven [Hospira Inc.]

These highlights do not include all the information needed to use Voluven safely and effectively. See full prescribing information for Voluven. VOLUVEN (6% HYDROXYETHYL STARCH 130/0.4 IN 0.9% SODIUM C...

Vinoperfect day perfecting spf 15 [Caudalie USA Inc.]


Clarins super restorative day [Laboratoires Clarins S.A.]

Clarins Super Restorative Day

Cupriminecapsules(penicillamine) [Merck & Co., Inc.]


Immortelle brightening shield and sunscreen spf 40 [L'Occitane SA]

Immortelle Brightening Shield And Sunscreen SPF 40

PubMed Articles [657 Associated PubMed Articles listed on BioPortfolio]

Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma.

The human leukocyte antigen (HLA)-G and HLA-E, non classical HLA class I molecules, have been highly implicated in immune tolerance. HLA-G and HLA-E molecules were proposed as putative markers of seve...

Erratum: Antonsen, S.; et al. Synthesis of Racemic β-Chamigrene, a Spiro5.5undecane Sequiterpene. Molecules 2014, 19, 20664-20670.

The Molecules Editorial Office wishes to make the following erratum to this paper [1].[...].

Extent of BOLD Vascular Dysregulation Is Greater in Diffuse Gliomas without Isocitrate Dehydrogenase 1 R132H Mutation.

Purpose To determine the effect that R132H mutation status of diffuse glioma has on extent of vascular dysregulation and extent of residual blood oxygen level-dependent (BOLD) abnormality after surgic...

DiCE: Diastereomeric in-silico Chiral Elucidation, Expanded DP4 Probability Theory Method for Diastereomer and Structural Assignment.

NMR chemical shift prediction at the B3LYP/cc-pVDZ level of theory was used to develop a highly accurate probability theory algorithm for determination of stereochemistry of diastereomers as well as r...

Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.

The formulae for Dice and Jaccard indices used to assess volumes concordance should read as follows.

Clinical Trials [324 Associated Clinical Trials listed on BioPortfolio]

Chidamide Plus DICE Regimen for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)

This is a prospective phase II clinical trial to observe the efficacy and safety of Chidamide combined with DICE (Dexamethasone, Ifosfamide, Cisplatin and Etoposide) in patients with relap...

Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma

The purpose of this study is to evaluate the efficacy and tolerability of the combination chemotherapy of DICE in the patients with NK/T cell lymphoma.

Decitabine Based Chemotherapy Followed by Haploidentical Lymphocyte Infusion for Elderly Patients With AML

Demethylating agent decitabine enhances the immunogenicity of leukemia cells by inducing the expression of cancer testis antigens (CTAs),MHC class I and II molecules,costimulatory molecule...

Adherence to Dolutegravir and Outcome

The main assumption is that the dolutegravir can get virologic suppression to suboptimal adherence levels (between 80 and 95%, and after treatment interruptions) where other molecules are ...

Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to Hemodiafiltration

Today it is well established that middle molecules comprise several compounds that are not effectively removed by high-flux dialyzers, and effective clearance of large middle molecules in ...

Companies [397 Associated Companies listed on BioPortfolio]

DiCE Molecules SV, LLC

DiCE Molecules is a privately held company focused on the development of small molecule compounds that unlock previously intractable targets. DiCE’s platform uniquely brings ...


Diaclone produces a large panel of monoclonals antibodies and kits to detect human, mouse and rat molecules playing key roles in the immune system (CDs, cytokines and adhesion molecules.

Alchemie Limited

Alchemia has become internationally recognised for its unique platform technology for the production of complex sugar-based molecules called oligosaccharides.Oligosaccharides play pivotal roles in man...

Xenome Limited

Xenome aims to develop new treatments for pain, particularly intractable pain as experienced by many cancer patients, as well as other neurological conditions for which there is an unmet clinical need...


The Molecular Design and Discovery (MDD) Incorporated is a North American company with its headquarter located in Mississauga, Ontario, Canada. The company is service provider of advanced chemical an...

More Information about "DiCE Molecules SV, LLC" on BioPortfolio

We have published hundreds of DiCE Molecules SV, LLC news stories on BioPortfolio along with dozens of DiCE Molecules SV, LLC Clinical Trials and PubMed Articles about DiCE Molecules SV, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DiCE Molecules SV, LLC Companies in our database. You can also find out about relevant DiCE Molecules SV, LLC Drugs and Medications on this site too.

Quick Search


Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record